Carmignac Gestion 13D and 13G filings for Clearside Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 12:19 pm Sale |
2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
Carmignac Gestion | 2,400,344 3.980% |
-723,908 (-23.17%) |
Filing |
| 2022-02-09 2:09 pm Sale |
2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
Carmignac Gestion | 3,124,252 5.200% |
-416,709 (-11.77%) |
Filing |
| 2021-02-12 12:25 pm Purchase |
2020-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
Carmignac Gestion | 3,540,961 7.300% |
3,540,961 (New Position) |
Filing |